Dr. Gray’s research focuses on applying advanced measurement technologies to identify the genomic abnormalities that occur in breast cancers. Dr. Gray uses information from his studies to improve aspects of breast cancer management, ranging from early detection to better treatment of metastatic disease. Dr. Gray’s Komen supported research aims to understand how the environment that surrounds a tumor combined with the tumor’s genetics impact its response to therapy, with a special focus on HER2-positive tumor.
Metastatic breast cancer is not just science for Dr. Gray, as his wife, Jane, is living with the disease. Please join us as we learn more about the latest research and clinical trials from Dr. Gray.
Tickets for the luncheon are $15 per person. Scholarships are available for breast cancer survivors. For scholarship information call Emily Richards at 208-384-0013 or email at firstname.lastname@example.org.